{"organizations": [], "uuid": "c874187b0923a281d26b411affebfcb6d10ab4f2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/europe", "section_title": "European Stock Market News | Reuters.com", "url": "https://www.reuters.com/article/brief-novartis-says-health-canada-approv/brief-novartis-says-health-canada-approved-kisqali-as-initial-therapy-for-certain-breast-cancer-patients-idUSFWN1S90M2", "country": "US", "domain_rank": 408, "title": "BRIEF-Novartis Says Health Canada Approved Kisqali As Initial Therapy For Certain Breast Cancer Patients", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.996, "site_type": "news", "published": "2018-05-02T20:25:00.000+03:00", "replies_count": 0, "uuid": "c874187b0923a281d26b411affebfcb6d10ab4f2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-novartis-says-health-canada-approv/brief-novartis-says-health-canada-approved-kisqali-as-initial-therapy-for-certain-breast-cancer-patients-idUSFWN1S90M2", "ord_in_thread": 0, "title": "BRIEF-Novartis Says Health Canada Approved Kisqali As Initial Therapy For Certain Breast Cancer Patients", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}], "organizations": [{"name": "novartis ag", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-novartis says health canada approved kisqali", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 2 (Reuters) - Novartis AG:\n* HEALTH CANADA APPROVES KISQALIâ„¢ FOR THE TREATMENT OF HR-POSITIVE AND HER2-NEGATIVE METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN IN COMBINATION WITH LETROZOLE AS AN INITIAL ENDOCRINE-BASED THERAPY Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-02T20:25:00.000+03:00", "crawled": "2018-05-02T18:24:39.051+03:00", "highlightTitle": ""}